Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Iuliana Darasteanu"'
Autor:
Arnaud de La Blanchardière, Louis Bernard, Jean-Paul Viard, T. Pasdeloup, Trulight Study Team, Laurent Hocqueloux, Véronique Avettand-Fenoel, Renaud Verdon, Gwenael Le Moal, Diane Ponscarme, Faiza Ajana, Gilles Pialoux, Mariam Roncato-Saberan, Thierry Prazuck, Manuel Etienne, Jean-Jacques Parienti, Iuliana Darasteanu, Simon Sunder
Publikováno v:
Journal of Antimicrobial Chemotherapy. 76:1564-1572
Objectives Low HIV reservoirs may be associated with viral suppression under a lower number of antiretroviral drugs. We investigated tenofovir disoproxil fumarate/emtricitabine as a maintenance strategy in people living with HIV (PLHIV) with low HIV-
Autor:
Sylvie, Rozenberg, Emillie, Lanoy, Michelle, Bentata, Jean-Paul, Viard, Marc Antoine, Valantin, Pascale, Missy, Iuliana, Darasteanu, Christian, Roux, Sami, Kolta, Dominique, Costagliola, L, Pittet-Barbier
Publikováno v:
AIDS research and human retroviruses. 28(9)
Low bone mineral density (BMD) is common in HIV-infected patients. Bisphosphonates such as alendronate potently inhibit bone resorption and are effective against osteoporosis. The aim of the ANRS 120 Fosivir trial was to evaluate the effect of alendr
Autor:
Pascale Missy, M. Bentata, Sylvie Rozenberg, Christian Roux, Marc-Antoine Valantin, Sami Kolta, Murielle Mary-Krause, Iuliana Darasteanu, Jean-Paul Viard, Béatrice Ename-Mkoumazok, Dominique Costagliola
Publikováno v:
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry. 15(4)
We analyzed data collected during screening for eligibility in the ANRS-120 FOSIVIR clinical trial to estimate the prevalence of osteoporosis in patients infected with human immunodeficiency virus 1 (HIV-1), to study its risk factors, and to develop